| Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart … AP Maggioni, SD Anker, U Dahlström, G Filippatos, P Ponikowski, ... European journal of heart failure 15 (10), 1173-1184, 2013 | 780 | 2013 |
| Initiation of sacubitril/valsartan in haemodynamically stabilised heart failure patients in hospital or early after discharge: primary results of the randomised TRANSITION study R Wachter, M Senni, J Belohlavek, E Straburzynska‐Migaj, KK Witte, ... European journal of heart failure 21 (8), 998-1007, 2019 | 355 | 2019 |
| Acute heart failure congestion and perfusion status–impact of the clinical classification on in‐hospital and long‐term outcomes; insights from the ESC‐EORP‐HFA Heart Failure … O Chioncel, A Mebazaa, AP Maggioni, VP Harjola, G Rosano, C Laroche, ... European journal of heart failure 21 (11), 1338-1352, 2019 | 222 | 2019 |
| Effects of Serelaxin in Patients with Acute Heart Failure. RAHFCI Metra M, Teerlink JR, Cotter G, et al. N Engl J Med. 381 (8), 716-726, 2019 | 217* | 2019 |
| The patient perspective: quality of life in advanced heart failure with frequent hospitalisations MS Nieminen, K Dickstein, C Fonseca, JM Serrano, J Parissis, F Fedele, ... International journal of cardiology 191, 256-264, 2015 | 197 | 2015 |
| In‐hospital and 1‐year mortality associated with diabetes in patients with acute heart failure: results from the ESC‐HFA Heart Failure Long‐Term Registry G Targher, M Dauriz, C Laroche, PL Temporelli, M Hassanein, ... European journal of heart failure 19 (1), 54-65, 2017 | 162 | 2017 |
| Performance of prognostic risk scores in chronic heart failure patients enrolled in the European Society of Cardiology Heart Failure Long-Term Registry M Canepa, C Fonseca, O Chioncel, C Laroche, MG Crespo-Leiro, ... JACC: Heart Failure 6 (6), 452-462, 2018 | 140 | 2018 |
| Levosimendan beyond inotropy and acute heart failure: evidence of pleiotropic effects on the heart and other organs: an expert panel position paper D Farmakis, J Alvarez, TB Gal, D Brito, F Fedele, C Fonseca, AC Gordon, ... International Journal of Cardiology 222, 303-312, 2016 | 139 | 2016 |
| Physicians' guideline adherence is associated with long‐term heart failure mortality in outpatients with heart failure with reduced ejection fraction: the QUALIFY international … M Komajda, J Schöpe, S Wagenpfeil, L Tavazzi, M Böhm, P Ponikowski, ... European Journal of Heart Failure 21 (7), 921-929, 2019 | 112 | 2019 |
| Organization of heart failure management in European Society of Cardiology member countries: survey of the Heart Failure Association of the European Society of Cardiology in … PM Seferović, S Stoerk, G Filippatos, V Mareev, A Kavoliuniene, AD Ristić, ... European journal of heart failure 15 (9), 947-959, 2013 | 112 | 2013 |
| Levosimendan efficacy and safety: 20 years of SIMDAX in clinical use Z Papp, P Agostoni, J Alvarez, D Bettex, S Bouchez, D Brito, V Cerný, ... Journal of cardiovascular pharmacology 76 (1), 4-22, 2020 | 111 | 2020 |
| Unravelling the interplay between hyperkalaemia, renin–angiotensin–aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC‐HFA … P Rossignol, M Lainscak, MG Crespo‐Leiro, C Laroche, MF Piepoli, ... European journal of heart failure 22 (8), 1378-1389, 2020 | 107 | 2020 |
| Effect of sacubitril/valsartan vs standard medical therapies on plasma NT-proBNP concentration and submaximal exercise capacity in patients with heart failure and preserved … B Pieske, R Wachter, SJ Shah, A Baldridge, P Szeczoedy, G Ibram, V Shi, ... Jama 326 (19), 1919-1929, 2021 | 89 | 2021 |
| Sex‐and age‐related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long‐Term Registry M Lainščak, I Milinković, M Polovina, MG Crespo‐Leiro, LH Lund, ... European journal of heart failure 22 (1), 92-102, 2020 | 84 | 2020 |
| European cardiomyopathy pilot registry: EURObservational research programme of the European society of cardiology P Elliott, P Charron, JRG Blanes, L Tavazzi, M Tendera, M Konte, ... European heart journal 37 (2), 164-173, 2016 | 78 | 2016 |
| Expert consensus on the monitoring of transthyretin amyloid cardiomyopathy P Garcia‐Pavia, F Bengel, D Brito, T Damy, F Duca, S Dorbala, ... European journal of heart failure 23 (6), 895-905, 2021 | 77 | 2021 |
| Sarcomeric hypertrophic cardiomyopathy: genetic profile in a Portuguese population D Brito, G Miltenberger-Miltenyi, SV Pereira, D Silva, AN Diogo, ... Revista Portuguesa de Cardiologia (English Edition) 31 (9), 577-587, 2012 | 68 | 2012 |
| A comprehensive characterization of acute heart failure with preserved versus mildly reduced versus reduced ejection fraction–insights from the ESC‐HFA EORP Heart Failure Long … A Kapłon‐Cieślicka, L Benson, O Chioncel, MG Crespo‐Leiro, AJS Coats, ... European Journal of Heart Failure 24 (2), 335-350, 2022 | 57 | 2022 |
| Omecamtiv mecarbil in chronic heart failure with reduced ejection fraction: GALACTIC‐HF baseline characteristics and comparison with contemporary clinical trials JR Teerlink, R Diaz, GM Felker, JJV McMurray, M Metra, SD Solomon, ... European journal of heart failure 22 (11), 2160-2171, 2020 | 55 | 2020 |
| N-Terminal Pro-Brain Natriuretic Peptide Shows Diagnostic Accuracy for Detecting Atrial Fibrillation in Cryptogenic Stroke Patients AC Fonseca, D Brito, TP e Melo, R Geraldes, P Canhão, LR Caplan, ... International Journal of Stroke 9 (4), 419-425, 2014 | 55 | 2014 |
Fausto PintoProfessor of Cardiology, Lisbon University Medical SchoolVerified email at medicina.ulisboa.pt
